Summary
Johnson & Johnson (JNJ) announced a significant event on December 15, 2004: the entry into an Agreement and Plan of Merger with Guidant Corporation. This filing details the terms of a business combination where JNJ's subsidiary, Shelby Merger Sub, Inc., will merge with Guidant. The transaction is structured as a "merger of equals" with a mixed consideration, offering Guidant shareholders a combination of cash and JNJ common stock. The value of the stock component is subject to a collar based on JNJ's volume-weighted average trading price for a specific period leading up to closing.
Key Highlights
- 1Johnson & Johnson entered into a merger agreement with Guidant Corporation on December 15, 2004.
- 2The transaction involves JNJ acquiring Guidant through a merger of its subsidiary, Shelby Merger Sub, Inc., with Guidant.
- 3Guidant shareholders will receive a combination of $30.40 in cash and JNJ common stock per share.
- 4The value of the stock component in the merger consideration is subject to a collar based on JNJ's stock price.
- 5The merger is contingent upon approval by Guidant shareholders and regulatory clearance, including HSR and EU merger control.
- 6Both companies have entered into customary representations, warranties, and covenants, with restrictions on Guidant soliciting alternative transactions.
- 7Termination fees are stipulated for both parties under specific circumstances: up to $750 million for Guidant and $700 million for JNJ.
Frequently Asked Questions
This 8-K filing announces that Johnson & Johnson has entered into a material definitive agreement to merge with Guidant Corporation. It outlines the key terms of the merger agreement, including the consideration to be paid to Guidant shareholders and the conditions for closing the transaction.
Guidant shareholders will receive a combination of $30.40 in cash and shares of Johnson & Johnson common stock. The number of JNJ shares will have a target value of $45.60, but this is subject to adjustment based on JNJ's stock price performance within a specified range prior to closing.
The merger is subject to several conditions, including the approval of Guidant shareholders, clearance under antitrust regulations (Hart-Scott-Rodino and European Union), and other customary closing conditions.
Yes, the merger agreement includes termination rights for both Johnson & Johnson and Guidant. Under certain circumstances, Guidant may be required to pay JNJ a termination fee of up to $750 million, and JNJ may be required to pay Guidant a termination fee of up to $700 million.